BEVERLEY ISHERWOOD

Partnership Lead, Medicines Discovery Catapult

Dr Beverley Isherwood is a Partnership Lead at the Medicines Discovery Catapult with responsibility for the Infectious Disease portfolio and a broad background across therapeutic areas and modalities gained from roles in and at the interface with the private, public and charity sectors. MDC is part of the Catapult national innovation infrastructure and works to reshape medicines discovery for patient benefit through connecting and collaborating with others. This included the role MDC played in creating the UK Lighthouse Lab Network in response to the COVID-19 pandemic. MDC has continuing interest in supporting the community to develop the vaccines, antimicrobials and diagnostics needed that can deliver to our future healthcare preparedness.